Large-body radiation doses following radioiodine therapy

Nuclear Medicine Communications

Volumn 23, Issue 11, 2002, Pages 1091-1097

  Leslie, W D ^a   Havelock, J ^a   Palser, R ^a   Abrams, D N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Dosimetry; Iodine 131; Radiation protection; Radioiodine

Indexed keywords

RADIOACTIVE IODINE; IODINE 131;

ADULT; ARTICLE; CHILD; COMPARATIVE STUDY; ENVIRONMENTAL EXPOSURE; EVALUATION; FEMALE; HUMAN; MALE; METHODOLOGY; RADIATION DOSE; RADIOMETRY; SENSITIVITY AND SPECIFICITY; THERMOLUMINESCENCE DOSIMETRY; THYROID DISEASE; WHOLE BODY COUNTING; DOSE CALCULATION; DOSE RESPONSE; DOSIMETRY; GEOMETRY; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PHANTOM; PRACTICE GUIDELINE; RADIATION ATTENUATION; RADIATION EXPOSURE; RADIATION PROTECTION; RADIOTHERAPY; THYROID CANCER; WHOLE BODY RADIATION;

ADULT; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; RADIATION DOSAGE; RADIOMETRY; SENSITIVITY AND SPECIFICITY; THERMOLUMINESCENT DOSIMETRY; THYROID DISEASES; WHOLE-BODY COUNTING;

EID: 0036855410     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200211000-00009     Document Type: Article

References (19)

1. Group of Medical Advisers. Guidelines on the management of patients treated with iodine-131 (GMA-4). Atomic Energy Control Board, Ottawa, Canada, 1993.
2. International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Oxford: Pergamon Press, 1991.
3. Mountford PJ, O'Doherty MJ. Restrictions following iodine-131 treatment - a time for change or more data required? Eur J Nucl Med 1994; 21: 903-905.
4. Culver CM, Dworkin HJ. Radiation safety considerations for post-iodine-131 hyperthyroid therapy. J Nucl Med 1991; 32: 169-173.
5. 131I treatment of thyrotoxic outpatients. Nucl Med Commun 1993; 14: 756-760.
6. 131I therapy for thyrotoxicosis. Nucl Med Commun 1993; 14: 160-168.
7. Barrington SF, Kettle AG, O'Doherty MJ, Wells CP, Somer EJR, Coakley AJ. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med 1996; 23: 123-130.
8. Brandrup J, Immergut EH, eds. Polymer handbook. 3rd edn. Chichester: Wiley, 1989.
9. International Commission on Radiological Protection. Report of the Task Force on Reference Man. ICRP Publication 23. Oxford: Pergamon Press, 1975.
10. Roche AV, Malina RM. Manual of physical status & performance in childhood. New York: Plenum Press, 1983.
11. Schneider S, McGuire SA. Regulatory analysis on criteria for the release of patients administered radioactive material. USNRC, NUREG-1492, February 1997.
12. 131I. Nucl Med Commun 1991; 12: 485-495.
13. Rose MR, Prescott MC, Herman KJ. Excretion of iodine-123-hippuran, technetium-99m-red blood cells, and technetium-99m-macroaggregated albumin into breast milk. J Nucl Med 1990; 31: 978-984.
14. Cormack J, Shearer J. Calculation of radiation exposures from patients to whom radioactive materials have been administered. Phys Med Biol 1998; 43: 501-516.
15. Buchan RCT, Brindle JM. Radioiodine therapy to out-patients - the radiation hazard. Br J Radiol 1971; 44: 973-975.
16. Barrington SF, O'Doherty MJ, Kettle AG, Thomson WH, Mountford PJ, Burrell DN, et al. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur J Nucl Med 1999; 26: 686-692.
17. 131I) therapy for thyroid carcinoma. JAMA 2000; 283: 2272-2274.
18. Caldwell CB, Ehrlich LE. Outpatient treatment of thyroid cancer using high doses of iodine 131. Can Assoc Radiol J 1999; 50: 331-336.
19. Beierwaltes WH, Widman J. How harmful to others are iodine-131 treated patients? J Nucl Med 1992; 33: 2116-2117.